STORE LOCATOR

Call Us at +91 8585858229

BG K9 Botoplexx Treatment

3,300.0016,800.00

Key Ingredients
Hair Type
Heena Coated Hair, Dyed Hair, Course Thick Hair, Virgin Hair, Prelightened Highlights, Prelightened ombre, Global Prelightened Weak Hair, Virgin Curly Hair, Coloured Curly Hair, Wavy hair.
pH level
Packaging
100 ml & 800 ml

Description

  • Formulated with an exclusive complex technology of oils and proteins that ensures the hair fiber alignment into desired shape. Its gel consistency provides a better product absorption, making the application easier and faster. It contains blue pigments that avoid color fading and blonde yellowing, common in other kinds of free formaldehyde formulas.
  • Botoplexx is an advanced smoothing, repairing, and bonding treatment specifically formulated for over processed and damaged hair. This unique all-in-one product is the first of its kind on the market, which is a fusion of three product concepts into one. Hair Biotin, Collagen, and plex. Biotin for hair doesn’t actually contain the ingredient of botulinum toxin,
  • The active ingredient in Botoplexx entered inside cortex and work inside of amino acid chains & through a process of deportation Hydrogen bond will be disassociate from sulpher bond and gives hair a healthy, extra shine, smooth & super straight look.
  • Botoplexx is having fusion of plex too, which is the original bond builder or we can say it’s a bond multiplier or create an artificial bond. Our patented active chemistry works on a molecular level to repair damaged and broken bonds.
  • Repair the broken bonds and rejuvenate hair. Increase tensile strength and restore elasticity. protect hair follicle from further damages.

Additional information

SIZE

100ml, 800ml

Reviews

There are no reviews yet.

Be the first to review “BG K9 Botoplexx Treatment”

Your email address will not be published. Required fields are marked *

four + sixteen =

Shopping cart2
-
+
-
+
Subtotal
2,898.31 (ex. VAT)
Total
3,420.00
Continue shopping
2

Submit the form to redirect to Investor Relations page